(Q43136155)

14 November 2017

A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease (English)

1 reference

14 November 2017

2

Kazuteru Ohashi

1 reference

14 November 2017

8

Hisashi Sakamaki

1 reference

14 November 2017

Chie Onishi

1

1 reference

14 November 2017

Takeshi Sawada

3

1 reference

14 November 2017

Mikako Nakano

4

1 reference

14 November 2017

Takeshi Kobayashi

5

1 reference

14 November 2017

Takuya Yamashita

6

1 reference

14 November 2017

Hideki Akiyama

7

1 reference

14 November 2017

10 March 2010

1 reference

International Journal of Hematology

14 November 2017

1 reference

14 November 2017

91

1 reference

14 November 2017

3

1 reference

14 November 2017

464-470

1 reference

https://scigraph.springernature.com/pub.10.1007/s12185-010-0516-x

14 November 2017

0 references

cites work

Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients

1 reference

12 December 2020

Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation

1 reference

12 December 2020

Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone

1 reference

12 December 2020

Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease

1 reference

12 December 2020

Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients.

1 reference

12 December 2020

Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.

1 reference

12 December 2020

Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity

1 reference

12 December 2020

Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient

1 reference

12 December 2020

Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation

1 reference

12 December 2020

Low-dose antithymocyte globulin for treatment of steroid-pulse-resistant acute graft-versus-host disease.

1 reference

12 December 2020

Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus

1 reference

12 December 2020

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

1 reference

12 December 2020

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group

1 reference

12 December 2020

Pharmacokinetics-based optimal dose-exploration of mycophenolate mofetil in allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Prevention and treatment of acute GvHD.

1 reference

12 December 2020

Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease.

1 reference

12 December 2020

IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade

1 reference

12 December 2020

Clinical features of allogeneic hematopoietic stem cell transplantation-associated organizing pneumonia

1 reference

12 December 2020

Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience

1 reference

12 December 2020

Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.

1 reference

12 December 2020

Bioavailability improvement of mycophenolic acid through amino ester derivatization

1 reference

12 December 2020

Lymphocyte-Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide Depletion

1 reference

12 December 2020

10.1007/S12185-010-0516-X

Identifiers

DOI

1 reference

14 November 2017

1 reference